CVR: 16279099
Secondary names: SCANZYM A/S, SCANDRUG A/S, PHARMANOVA A/S
Previous names: A/S PSE NR. 4681, A/S SCANPHARM AF 1992, SCANPHARM A/S AF 1992
DKK 29,716,677
Gross profit
Net result: DKK 962,722
CHLOPETHAN A/S, Peluli Holding ApS
CVR · view ownership and management
Owner registered: CHLOPETHAN A/S
CVR · 01/03/2019
View the full event history
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.
Source: annual report 2025, Danish Business Authority
The financial health of SCANPHARM A/S shows signs of recovery, with gross profit increasing from 11.26 million DKK in 2021 to 29.72 million DKK in 2025, indicating a positive growth trajectory. However, profitability remains a concern, as the company reported losses in the previous years, with a notable loss of 10.87 million DKK in 2021, which has since improved to a profit of 962,722 DKK in 2025. Equity has steadily increased from 1.5 million DKK in 2021 to 3.05 million DKK in 2025, reflecting a strengthening financial position. Despite these improvements, the absence of revenue data raises questions about the company's market position and overall stability within the pharmaceutical manufacturing industry.
AI-generated summary · Generated 16/08/2026
Selskabets formål er at drive handel og produktion
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 29.7 mio. | 963 t. | 39.2 mio. | 3 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 26.9 mio. | 583 t. | 35.1 mio. | 2.1 mio. | 42 | |
| 202301/01/2023 – 31/12/2023 | 22.5 mio. | -4.4 mio. | 31.6 mio. | 1.5 mio. | 44 | |
| 202201/01/2022 – 31/12/2022 | 17.4 mio. | -6 mio. | 29.7 mio. | 1.5 mio. | 41 | |
| 202101/01/2021 – 31/12/2021 | 11.3 mio. | -10.9 mio. | 28.9 mio. | 1.5 mio. | 40 | |
| 202001/01/2020 – 31/12/2020 | 5.1 mio. | -18.9 mio. | 32.2 mio. | 1.9 mio. | 40 | |
| 201901/01/2019 – 31/12/2019 | 17.8 mio. | -4 mio. | 35.2 mio. | 5.9 mio. | 42 | |
| 201801/01/2018 – 31/12/2018 | 19.6 mio. | -2.9 mio. | 38.2 mio. | 9.9 mio. | 46 | |
| 201701/01/2017 – 31/12/2017 | 19.1 mio. | -228 t. | 41.5 mio. | 12.7 mio. | 43 | |
| 201601/01/2016 – 31/12/2016 | 19.6 mio. | 1.3 mio. | 33.4 mio. | 13 mio. | 42 | |
| 201501/01/2015 – 31/12/2015 | 20.4 mio. | 716 t. | 31.1 mio. | 11.7 mio. | 42 | |
| 201401/01/2014 – 31/12/2014 | 20.8 mio. | 431 t. | 33.7 mio. | 11 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 20.9 mio. | 400 t. | 34.5 mio. | 10.6 mio. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningSCANPHARM A/S was founded on 1 July 1992.
SCANPHARM A/S is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
SCANPHARM A/S had 51 employees in 2018 according to the Danish CVR register.
SCANPHARM A/S is owned by CHLOPETHAN A/S and Peluli Holding ApS.
In 2025, SCANPHARM A/S reported a gross profit of DKK 29,716,677.
The management of SCANPHARM A/S consists of Andreas Bjørn Jensen.
Claim this page to add your logo and social links. Free to get started.
SCANPHARM A/S has published its annual report for 2025. Gross profit came to DKK 29,716,677, and the net result was DKK 962,722.
Contact info changed: new phone: 45826046 (February 27, 2026).
As of February 25, 2026, Andreas Bjørn Jensen has joined the board of directors of SCANPHARM A/S.
As of February 25, 2026, Ole Bjørn Jensen has left the board of directors of SCANPHARM A/S.
SCANPHARM A/S has published its annual report for 2024. Gross profit came to DKK 26,903,798, and the net result was DKK 582,684.
SCANPHARM A/S has published its annual report for 2023. Gross profit came to DKK 22,519,429, and the net result was DKK -4,424,691.
SCANPHARM A/S has published its annual report for 2022. Gross profit came to DKK 17,399,136, and the net result was DKK -5,954,451.
SCANPHARM A/S has published its annual report for 2021. Gross profit came to DKK 11,259,429, and the net result was DKK -10,870,586.
As of January 6, 2022, Janus Doré Pagh has joined the board of directors of SCANPHARM A/S.
As of January 6, 2022, Holger Carsten Hansen has left the board of directors of SCANPHARM A/S.
SCANPHARM A/S has published its annual report for 2020. Gross profit came to DKK 5,118,414, and the net result was DKK -18,941,298.
SCANPHARM A/S has published its annual report for 2019. Gross profit came to DKK 17,829,889, and the net result was DKK -3,977,723.
SCANPHARM A/S has published its annual report for 2018. Gross profit came to DKK 19,563,917, and the net result was DKK -2,876,360.
As of March 1, 2019, CHLOPETHAN A/S is registered as an owner of SCANPHARM A/S with an ownership share of 90%.
As of February 28, 2019, Andreas Bjørn Jensen is registered as adm. dir. of SCANPHARM A/S.
As of February 28, 2019, Rolf Eckersberg has stepped down as director of SCANPHARM A/S.
SCANPHARM A/S has published its annual report for 2017. Gross profit came to DKK 19,072,265, and the net result was DKK -228,236.
As of January 30, 2018, Rolf Eckersberg is registered as director of SCANPHARM A/S.
As of January 30, 2018, Ole Bjørn Jensen has stepped down as director of SCANPHARM A/S.
As of January 22, 2018, Peluli Holding ApS is registered as an owner of SCANPHARM A/S with an ownership share of 10%.
SCANPHARM A/S has published its annual report for 2016. Gross profit came to DKK 19,626,649, and the net result was DKK 1,267,088.
SCANPHARM A/S has published its annual report for 2015. Gross profit came to DKK 20,446,816, and the net result was DKK 715,522.
SCANPHARM A/S has published its annual report for 2014. Gross profit came to DKK 20,769,828, and the net result was DKK 431,209.
SCANPHARM A/S has published its annual report for 2013. Gross profit came to DKK 20,949,478, and the net result was DKK 399,646.
SCANPHARM A/S has published its annual report for 2012.
As of October 14, 2010, Holger Carsten Hansen has joined the board of directors of SCANPHARM A/S.
As of October 14, 2010, Jens Terkel Lund-Nielsen has left the board of directors of SCANPHARM A/S.
As of June 5, 2007, Bent Lind Kofoed has been appointed auditor of SCANPHARM A/S.
As of June 5, 2007, REVISIONSFIRMAET A. ROLF LARSEN A/S has stepped down as auditor of SCANPHARM A/S.
As of May 31, 1999, Jens Terkel Lund-Nielsen has joined the board of directors of SCANPHARM A/S.
As of May 31, 1999, Kim Aage Egegaard has left the board of directors of SCANPHARM A/S.
On November 10, 1995, the company changed its name from SCANPHARM A/S AF 1992 to SCANPHARM A/S.
On July 6, 1993, the company changed its name from A/S SCANPHARM AF 1992 to SCANPHARM A/S AF 1992.
On January 6, 1993, the company changed its name from A/S PSE NR. 4681 to A/S SCANPHARM AF 1992.
As of January 5, 1993, Erik Tronborg Andersen has stepped down as auditor of SCANPHARM A/S.
As of January 5, 1993, Hans Christian Galst has left the board of directors of SCANPHARM A/S.
As of January 5, 1993, Ulf Svejgaard Poulsen has left the board of directors of SCANPHARM A/S.
As of January 5, 1993, Per Emil Hasselbalch Stakemann has left the board of directors of SCANPHARM A/S.
As of January 5, 1993, Per Emil Hasselbalch Stakemann has stepped down as director of SCANPHARM A/S.
As of July 1, 1992, Erik Tronborg Andersen has been appointed auditor of SCANPHARM A/S.
As of July 1, 1992, REVISIONSFIRMAET A. ROLF LARSEN A/S has been appointed auditor of SCANPHARM A/S.
As of July 1, 1992, Ole Bjørn Jensen has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Hans Christian Galst has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Kim Aage Egegaard has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Ulf Svejgaard Poulsen has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Per Emil Hasselbalch Stakemann has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Hanne Bjørn Jensen has joined the board of directors of SCANPHARM A/S.
As of July 1, 1992, Ole Bjørn Jensen is registered as director of SCANPHARM A/S.
As of July 1, 1992, Per Emil Hasselbalch Stakemann is registered as director of SCANPHARM A/S.
SCANPHARM A/S was founded on July 1, 1992.
Companies in the same industry and area
CVR 31603390
CVR 34459975
CVR 35419543
CVR 43730967
CVR 40259724
